These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 33512605)
1. Complication rates following ventricular tachycardia ablation in ischaemic and non-ischaemic cardiomyopathies: a systematic review. Ding WY; Pearman CM; Bonnett L; Adlan A; Chin SH; Denham N; Modi S; Todd D; Hall MCS; Mahida S J Interv Card Electrophysiol; 2022 Jan; 63(1):59-67. PubMed ID: 33512605 [TBL] [Abstract][Full Text] [Related]
2. Catheter Ablation for Ventricular Tachycardia in Ischaemic Versus Non-Ischaemic Cardiomyopathy: A Systematic Review and Meta-Analysis. Kanagaratnam A; Virk SA; Pham T; Anderson RD; Turnbull S; Campbell T; Bennett R; Thomas SP; Lee G; Kumar S Heart Lung Circ; 2022 Aug; 31(8):1064-1074. PubMed ID: 35643798 [TBL] [Abstract][Full Text] [Related]
3. Meta-analysis comparing outcomes of catheter ablation for ventricular arrhythmia in ischemic versus nonischemic cardiomyopathy. Basu-Ray I; Khanra D; Shah SK; Mukherjee A; Char SV; Jain B; Bunch TJ; Gold M; Adeboye AA; Saeed M Pacing Clin Electrophysiol; 2021 Jan; 44(1):54-62. PubMed ID: 33216394 [TBL] [Abstract][Full Text] [Related]
4. Long-term outcomes after catheter ablation of ventricular tachycardia in patients with and without structural heart disease. Kumar S; Romero J; Mehta NK; Fujii A; Kapur S; Baldinger SH; Barbhaiya CR; Koplan BA; John RM; Epstein LM; Michaud GF; Tedrow UB; Stevenson WG Heart Rhythm; 2016 Oct; 13(10):1957-63. PubMed ID: 27392945 [TBL] [Abstract][Full Text] [Related]
5. Outcomes of ventricular tachycardia ablation in patients with ischemic and non-ischemic cardiomyopathy: A propensity-score matched analysis. Gomes DA; Sousa Paiva M; Matos D; Bello AR; Rodrigues G; Carmo J; Ferreira J; Moscoso Costa F; Galvão Santos P; Carmo P; Cavaco D; Bello Morgado F; Adragão P Rev Port Cardiol; 2024 Jun; 43(6):341-349. PubMed ID: 38615878 [TBL] [Abstract][Full Text] [Related]
6. Comparison of the arrhythmogenic substrate for ventricular tachycardia in patients with ischemic vs non-ischemic cardiomyopathy - insights from high-density, multi-electrode catheter mapping. Kotake Y; Nalliah CJ; Campbell T; Bennett RG; Turnbull S; Kumar S J Interv Card Electrophysiol; 2023 Jan; 66(1):5-14. PubMed ID: 34787768 [TBL] [Abstract][Full Text] [Related]
7. Image Integration to Guide Catheter Ablation in Scar-Related Ventricular Tachycardia. Yamashita S; Sacher F; Mahida S; Berte B; Lim HS; Komatsu Y; Amraoui S; Denis A; Derval N; Laurent F; Sermesant M; Montaudon M; Hocini M; Haïssaguerre M; Jaïs P; Cochet H J Cardiovasc Electrophysiol; 2016 Jun; 27(6):699-708. PubMed ID: 26918883 [TBL] [Abstract][Full Text] [Related]
8. Characterization of the arrhythmogenic substrate in ischemic and nonischemic cardiomyopathy implications for catheter ablation of hemodynamically unstable ventricular tachycardia. Nakahara S; Tung R; Ramirez RJ; Michowitz Y; Vaseghi M; Buch E; Gima J; Wiener I; Mahajan A; Boyle NG; Shivkumar K J Am Coll Cardiol; 2010 May; 55(21):2355-65. PubMed ID: 20488307 [TBL] [Abstract][Full Text] [Related]
9. Endocardial substrate mapping for monomorphic ventricular tachycardia ablation in ischemic and non-ischemic cardiomyopathy. Fukuzawa K; Yoshida A; Kubo S; Takano T; Kiuchi K; Kanda G; Takami K; Kumagai H; Torii S; Takami M; Yokoyama M; Hirata K Kobe J Med Sci; 2008 Jul; 54(2):E122-35. PubMed ID: 18772614 [TBL] [Abstract][Full Text] [Related]
10. Beyond the Storm: Comparison of Clinical Factors, Arrhythmogenic Substrate, and Catheter Ablation Outcomes in Structural Heart Disease Patients With versus Those Without a History of Ventricular Tachycardia Storm. Kumar S; Fujii A; Kapur S; Romero J; Mehta NK; Tanigawa S; Epstein LM; Koplan BA; Michaud GF; John RM; Stevenson WG; Tedrow UB J Cardiovasc Electrophysiol; 2017 Jan; 28(1):56-67. PubMed ID: 27781325 [TBL] [Abstract][Full Text] [Related]
11. Catheter ablation of ventricular tachycardia in ischaemic and non-ischaemic cardiomyopathy: where are we today? A clinical review. Wissner E; Stevenson WG; Kuck KH Eur Heart J; 2012 Jun; 33(12):1440-50. PubMed ID: 22411192 [TBL] [Abstract][Full Text] [Related]
12. Comparison of the Ventricular Tachycardia Circuit Between Patients With Ischemic and Nonischemic Cardiomyopathies: Detailed Characterization by Entrainment. Shirai Y; Liang JJ; Santangeli P; Arkles JS; Schaller RD; Supple GE; Nazarian S; Garcia FC; Lin D; Dixit S; Callans DJ; Marchlinski FE; Frankel DS Circ Arrhythm Electrophysiol; 2019 Jul; 12(7):e007249. PubMed ID: 31296041 [TBL] [Abstract][Full Text] [Related]
13. Predictors of long-term mortality after catheter ablation of ventricular tachycardia in a contemporary cohort of patients with structural heart disease. Darma A; Bertagnolli L; Dinov B; Torri F; Shamloo AS; Lurz JA; Dagres N; Husser-Bollmann D; Bollmann A; Hindricks G; Arya A Europace; 2020 Nov; 22(11):1672-1679. PubMed ID: 32830252 [TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of epicardial approach to catheter ablation of ventricular tachycardia - An institutional experience. Pandian J; Kaur D; Yalagudri S; Devidutta S; Sundar G; Chennapragada S; Narasimhan C Indian Heart J; 2017; 69(2):170-175. PubMed ID: 28460764 [TBL] [Abstract][Full Text] [Related]
15. Catheter Ablation of VT in Non-Ischaemic Cardiomyopathies: Endocardial, Epicardial and Intramural Approaches. Bhaskaran A; Tung R; Stevenson WG; Kumar S Heart Lung Circ; 2019 Jan; 28(1):84-101. PubMed ID: 30385114 [TBL] [Abstract][Full Text] [Related]
16. Epicardial ablation of ventricular tachycardia: an institutional experience of safety and efficacy. Tung R; Michowitz Y; Yu R; Mathuria N; Vaseghi M; Buch E; Bradfield J; Fujimura O; Gima J; Discepolo W; Mandapati R; Shivkumar K Heart Rhythm; 2013 Apr; 10(4):490-8. PubMed ID: 23246598 [TBL] [Abstract][Full Text] [Related]
17. Outcomes of Catheter Ablation of Ventricular Tachycardia Based on Etiology in Nonischemic Heart Disease: An International Ventricular Tachycardia Ablation Center Collaborative Study. Vaseghi M; Hu TY; Tung R; Vergara P; Frankel DS; Di Biase L; Tedrow UB; Gornbein JA; Yu R; Mathuria N; Nakahara S; Tzou WS; Sauer WH; Burkhardt JD; Tholakanahalli VN; Dickfeld TM; Weiss JP; Bunch TJ; Reddy M; Callans DJ; Lakkireddy DR; Natale A; Marchlinski FE; Stevenson WG; Della Bella P; Shivkumar K JACC Clin Electrophysiol; 2018 Sep; 4(9):1141-1150. PubMed ID: 30236386 [TBL] [Abstract][Full Text] [Related]
18. Combined Endocardial-Epicardial Versus Endocardial Catheter Ablation Alone for Ventricular Tachycardia in Structural Heart Disease: A Systematic Review and Meta-Analysis. Romero J; Cerrud-Rodriguez RC; Di Biase L; Diaz JC; Alviz I; Grupposo V; Cerna L; Avendano R; Tedrow U; Natale A; Tung R; Kumar S JACC Clin Electrophysiol; 2019 Jan; 5(1):13-24. PubMed ID: 30678778 [TBL] [Abstract][Full Text] [Related]
19. Can ventricular tachycardia non-inducibility after ablation predict reduced ventricular tachycardia recurrence and mortality in patients with non-ischemic cardiomyopathy? A meta-analysis of twenty-four observational studies. Hu J; Zeng S; Zhou Q; Zhu W; Xu Z; Yu J; Hong K Int J Cardiol; 2016 Nov; 222():689-695. PubMed ID: 27521538 [TBL] [Abstract][Full Text] [Related]
20. Impact of Number of Oral Antiarrhythmic Drug Failures Before Referral on Outcomes Following Catheter Ablation of Ventricular Tachycardia. Romero J; Stevenson WG; Fujii A; Kapur S; Baldinger SH; Mehta NK; John RM; Michaud GF; Epstein LM; Koplan BA; Tedrow UB; Kumar S JACC Clin Electrophysiol; 2018 Jun; 4(6):810-819. PubMed ID: 29929675 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]